REGENXBIO Inc. (RGNX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

51.57M
Year ended 2025-12-31
+6.1%
3-year compound annual growth
+6.7%
5-year compound annual growth
2016-12-31: 26.41M2017-12-31: 29.88M2018-12-31: 36.65M2019-12-31: 36.69M2020-12-31: 37.28M2021-12-31: 43.91M2022-12-31: 43.15M2023-12-31: 43.73M2024-12-31: 49.51M2025-12-31: 51.57M51.57M
2016-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3151.57M+4.2%2026-03-05, From 2025-01-01
2024-12-3149.51M+13.2%2026-03-05, From 2024-01-01
2023-12-3143.73M+1.3%2025-03-13, From 2023-01-01
2022-12-3143.15M-1.7%2025-03-13, From 2022-01-01
2021-12-3143.91M+17.8%2024-02-27, From 2021-01-01
2020-12-3137.28M+1.6%2023-02-28, From 2020-01-01
2019-12-3136.69M+0.1%2022-03-01, From 2019-01-01
2018-12-3136.65M+22.7%2021-03-01, From 2018-01-01
2017-12-3129.88M+13.1%2020-02-26, From 2017-01-01
2016-12-3126.41Mn/a2019-02-27, From 2016-01-01